A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: James J. Harding, Joseph Patrick Erinjeri, Benjamin R. Tan, Kim Anna Reiss, Kabir Mody, Daniel Khalil, Hooman Yarmohammadi, Gregory Nadolski, Joseph Daniel Giardina, Marinela Capanu, Richard K. G. Do, Mikaela Bradley, Chayma Boussayoud, Emily Valentino, Taha Merghoub, William R. Jarnagin, Michael C. Soulen, Karen T. Brown, Ghassan K. Abou-Alfa
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890862870